FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

1168011000001109: Mesalazine 1g suppositories 28 suppository (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
22578101000001110 Mesalazine 1g suppositories 28 suppository (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
22578201000001115 Mesalazine 1g suppositories 28 suppository en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

7 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Mesalazine 1g suppositories 28 suppository Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Mesalazine 1g suppositories 28 suppository Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Mesalazine 1g suppositories 28 suppository Is pack of Product containing precisely mesalazine 1 gram/1 each conventional release rectal suppository (clinical drug) false Inferred relationship Existential restriction modifier
Mesalazine 1g suppositories 28 suppository Has active ingredient Mesalazine false Inferred relationship Existential restriction modifier
Mesalazine 1g suppositories 28 suppository VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Mesalazine 1g suppositories 28 suppository VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Mesalazine 1g suppositories 28 suppository Has manufactured dose form Suppository false Inferred relationship Existential restriction modifier
Mesalazine 1g suppositories 28 suppository Has VMP Product containing precisely mesalazine 1 gram/1 each conventional release rectal suppository (clinical drug) true Inferred relationship Existential restriction modifier
Mesalazine 1g suppositories 28 suppository Has specific active ingredient Mesalazine true Inferred relationship Existential restriction modifier
Mesalazine 1g suppositories 28 suppository Has dispensed dose form Suppository true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Pentasa 1g suppositories (Ferring Pharmaceuticals Ltd) 28 suppository Is a True Mesalazine 1g suppositories 28 suppository Inferred relationship Existential restriction modifier
Pentasa 1g suppositories (Pharmaram Ltd) 28 suppository Is a True Mesalazine 1g suppositories 28 suppository Inferred relationship Existential restriction modifier
Pentasa 1g suppositories (CST Pharma Ltd) 28 suppository Is a True Mesalazine 1g suppositories 28 suppository Inferred relationship Existential restriction modifier
Pentasa 1g suppositories (Waymade Healthcare Plc) 28 suppository Is a True Mesalazine 1g suppositories 28 suppository Inferred relationship Existential restriction modifier
Pentasa 1g suppositories (Sigma Pharmaceuticals Plc) 28 suppository Is a True Mesalazine 1g suppositories 28 suppository Inferred relationship Existential restriction modifier
Pentasa 1g suppositories (Mawdsley-Brooks & Company Ltd) 28 suppository Is a True Mesalazine 1g suppositories 28 suppository Inferred relationship Existential restriction modifier
Pentasa 1g suppositories (Originalis B.V.) 28 suppository Is a True Mesalazine 1g suppositories 28 suppository Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start